Medical Therapies: Progestins
other
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Progestins are a first-line therapy for endometriosis pain, comparable to other treatments with minimal side effects, especially useful when avoiding estrogen or contraception is desired.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Progestins have a valuable role in the treatment of the painful symptoms associated with endometriosis and should be considered a first-line therapy. They are comparable in efficacy to other medical approaches, such as estrogen-containing preparations and gonadotropin releasing hormone agonists, and have minimal adverse effects. In particular, progestins should be considered when it is necessary to avoid the effects of estrogen, or in women who do not need, or want, to use contraception. Progestins are available in many forms, including oral preparations, injections, subdermal implants and intrauterine systems. The levonorgestrel intrauterine system, delivering high-dose progestin with few systemic side-effects, is a particularly promising long-term management option for endometriosis. The mechanism of action of progestins in the treatment of painful symptoms of endometriosis is currently not known.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (53)
- Altered Gene Expression Profiling in Endometrium: Evidence for Progesterone Resistance via openalex
- Changes in quality of life after hormonal treatment of endometriosis via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Current place of progestins in the treatment of endometriosis-related complaints via openalex
- Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex
- Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Effect of norethindrone acetate in the treatment of symptomatic endometriosis. via openalex
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium via openalex
- Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study via openalex
- Endometrial Angiogenesis, Vascular Maturation, and Lymphangiogenesis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications via openalex
- Endometriosis-Related Pelvic Pain: What is the Evidence? via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex
- Expression Profiling of Endometrium from Women with Endometriosis Reveals Candidate Genes for Disease-Based Implantation Failure and Infertility via openalex
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
- Interval of Injections of Intramuscular Depot Medroxyprogesterone Acetate in the Long-Term Treatment of Endometriosis-Associated Pain: A Randomized Comparative Trial via openalex
- Levonorgestrel-Releasing Intrauterine System for the Treatment of Endometriosis: Biological and Clinical Evidence via openalex
- Levonorgestrel-releasing intrauterine system: uses and controversies via openalex
- Medical management of endometriosis: a systematic review. via openalex
- Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model via openalex
- Progestogens for endometriosis: forward to the past via openalex
- Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
- The place of dydrogesterone in the treatment of endometriosis and adenomyosis via openalex
- Treatment of pelvic pain associated with endometriosis via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2072195133 via openalex
- W2049319562 via openalex
- W2044060855 via openalex
- W2026781892 via openalex
- W2157853773 via openalex
- W1988034230 via openalex
- W1981675177 via openalex
- W1980402125 via openalex
- W1978085719 via openalex
- W2497131907 via openalex
- W1972596300 via openalex
- W2101417341 via openalex
- W6723391054 via openalex
- W2102395114 via openalex
- W2085922363 via openalex
- W2122902311 via openalex
- W2123134517 via openalex
Cited by (3)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-28T06:20:55.906821+00:00
License: CC0
· commercial use OK